Recent Events & Catalysts
Illumina, Inc. (ILMN) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
Score Changetoday
ILMN committee score fell 1.6 points
ILMN's Committee score moved from 54.88 to 53.25 (-1.63, 1 day(s) apart).
Agreement Shifttoday
ILMN analyst agreement shifted
ILMN's Committee agreement moved from 66.70% to 50.00% (-16.70pp, 1 day(s) apart).
Conviction Changetoday
ILMN conviction changed
ILMN's Committee conviction moved from moderate to contested (1 day(s) apart).
Score Changeyesterday
ILMN committee score fell 0.5 points
ILMN's Committee score moved from 55.39 to 54.88 (-0.51, 1 day(s) apart).
Score Change2d ago
ILMN committee score fell 0.8 points
ILMN's Committee score moved from 56.18 to 55.39 (-0.79, 1 day(s) apart).
Score Change4d ago
ILMN committee score fell 0.9 points
ILMN's Committee score moved from 57.12 to 56.18 (-0.94, 1 day(s) apart).
News
Is Grail (GRAL) Stock a Buy, Sell, or Hold at Under $70?
Yahoo · today
Illumina Q2 Earnings Call Highlights
Yahoo · today
ILMN Q2 Deep Dive: Clinical Strength, Platform Expansion, and Strategic Focus Drive Guidance Lift
Yahoo · today
Illumina CEO on Genomic Sequencing Opportunities and AI
Yahoo · 1d ago
Illumina, Inc. 2026 Q2 - Results - Earnings Call Presentation
SeekingAlpha · 1d ago
JP Morgan Maintains Overweight on Illumina, Raises Price Target to $230
Benzinga · 1d ago
TD Cowen Maintains Hold on Illumina, Raises Price Target to $210
Benzinga · 1d ago
Illumina, Inc. Q2 2026 Earnings Call Summary
Yahoo · 1d ago
SEC Filings (90 days)
Results of operations (earnings release), Financial statements and exhibits
Filed 2026-07-30 · 2d ago · Material
Departure/appointment of directors or officers
Filed 2026-06-23 · 39d ago
Submission of matters to a vote of security holders, Financial statements and exhibits
Filed 2026-05-26 · 67d ago
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.